SCHEMBL29759239

SCHEMBL29759239

COC(=O)c1cc(F)c(OC)c(Br)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TPMT P51580 1/20 0.51
NOTUM Q6P988 2/20 0.47
KDM4E B2RXH2 3/20 0.47
POLB P06746 2/20 0.47
LMNA P02545 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
GAA P10253 1/20 0.47
NFKB1 P19838 1/20 0.47
XDH P47989 1/20 0.47
GFER P55789 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
FUT7 Q11130 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
TSHR P16473 1/20 0.46
APOBEC3A P31941 1/20 0.46
HTT P42858 1/20 0.46
APOBEC3G Q9HC16 1/20 0.46
ALDH1A1 P00352 3/20 0.44
CA12 O43570 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1561433 1.00 TPMT (0.51) TPMTNOTUMKDM4EPOLBLMNA
SCHEMBL3349066 0.87 TPMT (0.59) TPMTNOTUMKDM4EPOLBLMNA
SCHEMBL8465292 0.87 KDM4E (0.55) NOTUMKDM4EPOLBLMNAL3MBTL1
SCHEMBL1560980 0.84 TPMT (0.67) TPMTLMNATSHRAPOBEC3AHTT
SCHEMBL31063258 0.84 TPMT (0.67) TPMTLMNATSHRAPOBEC3AHTT
SCHEMBL31063218 0.84 TPMT (0.49) TPMTLMNATSHRAPOBEC3AHTT
SCHEMBL23826331 0.84 NOTUM (0.43) TPMTNOTUMKDM4EPOLBLMNA
SCHEMBL34472958 0.84 TPMT (0.43) TPMTNOTUMLMNATSHRAPOBEC3A
SCHEMBL30628771 0.84 NOTUM (0.43) TPMTNOTUMKDM4EPOLBLMNA
SCHEMBL403251 0.83 NOTUM (0.42) TPMTNOTUMKDM4EPOLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4665458-A1 INHIBITING ALPHA V BETA8 INTEGRIN Morphic Therapeutic, Inc. (US) 2025-12-24 EP disclosed
EP-4665339-A1 INHIBITING ALPHA V BETA 8 INTEGRIN Morphic Therapeutic, Inc. (US) 2025-12-24 EP disclosed
WO-2025096751-A1 MACROCYCLIC INHIBITORS OF ATP CITRATE LYASE ESPERION THERAPEUTICS, INC. (US) 2025-05-08 WO disclosed
WO-2024173570-A1 INHIBITING αvβ8 INTEGRIN MORPHIC THERAPEUTIC, INC. (US) 2024-08-22 WO disclosed
WO-2024173572-A1 INHIBITING α vβ8 INTEGRIN MORPHIC THERAPEUTIC, INC. (US) 2024-08-22 WO disclosed
WO-2022129047-A2 NOVEL MODULATORS OF THE NMDA RECEPTOR H. LUNDBECK A/S (DK) 2022-06-23 WO disclosed